Panthera Biopartners debuts clinical trials in Preston

The newly formed Panthera Biopartners has begun three clinical trials at its new Preston home.

The company was created by Dr Ian Smith, who founded Chorley based clinical trials firm Synexus, and Professor John Lyon, who was previously a global executive in CRO Covance and a serial entrepreneur.

With a view to opening sites throughout the UK and beyond, Panthera launched in Preston with three trials underway and three more in the pipeline.

Panthera Biopartners has recruited a team of healthcare staff for its Preston site, all of whom are GCP trained with considerable experience in the recruiting of patients and running of clinical trials.

The team will initially recruit patients and run clinical trials in therapy areas which are traditionally managed in primary care including cardiac disease, allergies, migraine, osteoarthritis, osteoporosis and diabetes.

Dr Ian Smith, founder and medical director of Panthera, said: “It has been so encouraging talking to CROs and major pharma companies. They have really welcomed the entry of Panthera Biopartners as an independent SMO (Site Management Organisation) which incorporates new technology into the running of clinical trials and the recruitment of patients.

Major pharma companies have really welcomed the entry of Panthera Biopartners as an independent organisation.

"We plan to have a number of sites up and running by the first quarter of 2020 with an ongoing expansion program across the UK and overseas.”

Panthera will soon announce the appointment of a CEO and other senior roles.

  • For further Lancashire business news, advice and analysis subscribe to Lancashire Business View or join the LBV Hub from just £2.50 per month. Click here to subscribe now.